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Therapy Oncology Group (RTOG) protocol 1306. 
Determination of isocentre, beam arrangement and dose 
constraints were kept constant in each case. All plans were 
computed using Varian Eclipse version 11.0 treatment 
planning system. The plans were then evaluated based on the 
target coverage, homogeneity, conformity, number of 
monitor units (MU) to be delivered and dose-volume 
constraints for various organs at risk (OARs). 
 
Results: All plans exhibited comparable PTV homogeneity (HI 
≤ 7.5) and conformity (CI > 96%) with a steep dose fall-off 
outside the PTVs but at the expense of increased MUs by 
39.4% (p=0.007) and 44.7% (p=0.005) for FFF beams at 6 MV 
and 10 MV respectively. FFF beams offered better dose 
sparing of OARs than flattened beams. Spinal cord+5mm and 
volume of 'whole lung (WL) – Gross tumour volume (GTV)' 
(WL-GTV) that received 20Gy (V20) were reduced by 2% 
(p=0.017) and 2.8% (p=0.016) respectively in X10FFF plans 
when compared with X10FF plans. There was also a 16.4 % 
dose reduction to brachial plexus in X10FFF plans than X6FFF 
plans. 
 
Conclusion: The application of FFF IMRT for NSCLC yielded 
quantitatively comparable dosimetric distribution with better 
sparing of the OARs including ‘spinal cord+5mm’, V20 of ‘WL-
GTV’ and brachial plexus than using FF beams. 
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Purpose or Objective: There are few studies comparing 3-
dimensional conformal radiation therapy (3DCRT) and 
volumetric modulated arc therapy (VMAT) in treatment of 
esophageal cancer. These studies often compare 3DCRT 
unsophisticated, with few treatment beams, which is not 
common in clinical practice.  
Our aim was to compare a modern 3DCRT plan with VMAT 
using dose volume histograms (DVH) and evaluate the 
dosimetric profile.  
 
Material and Methods: We evaluate 7 patients with 
esophageal cancer (4 medium, 2 distal and 1 upper 
neoplasms). All were contoured using PET-CT and treated 
with radio-chemotherapy. Target volumes for primary lesions 
(50-50,4 Gy) and electively treated regions (45 Gy) were 
contoured. 
Every patient had 2 dose-plans, one with 3DCRT (8-10 beams) 
and other with VMAT (2 arcs) techniques. For each technique, 
we evaluate the coverage target, homogeneity index of PTV 
(HI), conformity index (CI), monitor units and DVH metrics of 
lungs, heart and spinal cord. 
 
Results: VMAT plans reduced total lung volume treated above 
20 Gy (V20) and mean lung dose (MLD), but volume treated 
above 5 Gy (V5) were higher than 3DCRT. VMAT improved 
total heart volume treated above 20 Gy and 40 Gy (V20, V40) 
and maximum dose to cord.  
Monitor units (MU) were higher with the 3DCRT. HI and CI are 
better with VMAT technique. Coverage target was very high 
with both schemes. Statistically meaningful differences were 
observed (Table 1). 
 
Conclusion: Our results suggest that VMAT for radical 
treatment of esophageal cancer is useful for decreasing dose 
in organs at risk. It can play a more important role in some 
locations, such as cervical cancer. Nevertheless, VMAT 
increases low-doses in lung and this may contribute increase 
pulmonary complications.  
A complex multibeam technique -3DCRT preserves constraint 
of organs at risk with high conformity and homogeneity of the 
target. 
 
 
PO-1003  
Does level of DIBH amplitude correlate to reduction in 
cardiac dose in left breast cancer patients? 
D. Ledsom
1Clatterbridge Cancer Centre, Radiotherapy, Bebington, 
United Kingdom 
1, A. Reilly2, H. Probst3 
2Clatterbridge Cancer Centre, Physics, Bebington, United 
Kingdom 
3Sheffield Hallam University, Faculty of Health and 
Wellbeing, Sheffield, United Kingdom 
 
Purpose or Objective: The aim was to investigate whether 
the amplitude level achieved during DIBH impacted on the 
mean cardiac dose and V30 reduction in 30 women treated 
for a left sided breast cancer during radiotherapy. 
 
Material and Methods: Patients were dual scanned in free 
breathing and DIBH. Varian Real-time Position Management 
(RPM) was used to record and monitor breathing. Plans were 
virtually simulated with field borders following IMPORT high 
guidelines. Pinnacle treatment planning software was used 
for dosimetric calculation; all plans conformed to ICRU 62. 
Spearman’s Rank correlation and statistical analysis was 
performed using SPSS v22. All patient data was annonymised. 
To improve reliability and assess validity of the researcher, 
10 of the 30 patients were chosen at random, re-outlined and 
re-planned to confirm consistency and intra-rater reliability. 
The heart was also re-contoured for one patient 5 times to 
calculate the error in heart contouring. 
 
Results: All patients achieved decreased cardiac V30 and 
mean cardiac dose reduction using DIBH technique. Moderate 
positive correlation between DIBH amplitude and cardiac V30 
reduction was statistically significant (p=0.007, R=0.48). 
Ratio increase from free breathing to DIBH and cardiac V30 
reduction was also positively correlated and statistically 
significant (p=0.04, R=0.38). Twenty seven percent of 
patients achieved full cardiac V30 reduction and 73% of 
patients achieved over 90% reduction. Ratio of amplitude 
increase from free breathing to DIBH ranged from 4-27 times 
with ratios of at least 15 times free breathing all achieving 
100% cardiac V30 reduction. However 100% cardiac V30 
reduction was observed with amplitude of ratio increase as 
low as 6.25 times free breathing.  
Positive correlation between DIBH amplitude and mean 
cardiac dose reduction was statistically significant (p=0.003, 
R=0.523). Seventy seven percent of patients achieved over 
50% mean cardiac dose reduction with DIBH amplitudes of 
1.04-5.46cm. Correlation of ratio of amplitude increase from 
free breathing to DIBH and mean cardiac dose reduction was 
not statistically significant (p=0.316, R=0.189). 
 
Conclusion: A 100% reduction in cardiac V30 can be achieved 
with a DIBH amplitude increase 15 times free breathing, yet 
full reduction can also be achieved at much lower levels 
(6.25 times free breathing in the current study) suggesting 
patients unable to achieve a large amplitude increase may 
